Aljieyo Wart Remover Patch
NDC Package 83809-003-01
Package Information
Aljieyo Wart Remover patches is a medication used on the skin to treat common skin and foot (plantar) warts. This formulation utilizes a patch delivery system. Marketed by Shenzhen Yikai Electronic Technology Co., Ltd., this product is identified by NDC 83809-003 and is authorized under FDA application M005.
Identification & Billing
- RxCUI: 2670162 - salicylic acid 12 % Medicated Patch
- RxCUI: 2670162 - salicylic acid 0.12 MG/MG Medicated Patch
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 83809 - Shenzhen Yikai Electronic Technology Co., Ltd.
- 83809-003 - Aljieyo Wart Remover
- 83809-003-01 - 180 PATCH in 1 BOX
- 83809-003 - Aljieyo Wart Remover
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (83809-003). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 83809-003-01 identifies a specific commercial package of 180 patch in 1 box of Aljieyo Wart Remover, a human over the counter drug labeled by Shenzhen Yikai Electronic Technology Co., Ltd.. This patch is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shenzhen Yikai Electronic Technology Co., Ltd. on November 20, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used on the skin to treat common skin and foot (plantar) warts. Salicylic acid helps cause the wart to gradually peel off. This medication is also used to help remove corns and calluses. This product should not be used on the face or on moles, birthmarks, warts with hair growing from them, or genital/anal warts. Salicylic acid is a keratolytic. It belongs to the same class of drugs as aspirin (salicylates). It works by increasing the amount of moisture in the skin and dissolving the substance that causes the skin cells to stick together. This makes it easier to shed the skin cells. Warts are caused by a virus. Salicylic acid does not affect the virus.
How is this Shenzhen Yikai Electronic Technology Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 83809000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.